Healthcare -
Biotechnology - NASDAQ - GB
$ 57.541
0.526 %
$ 4.71 B
Market Cap
-28.77
P/E
Price Target
Average
--17.82%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--31.66%
Net Income
Estimate
160.60%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Verona Pharma plc
Wall Street analysts predict an average 1-year price target for VRNA of $47.3 , with forecasts ranging from
a
low of
$36 to a high of $74 .
VRNA Lowest Price Target
Wall Street Target
36 USD
-37.44%
VRNA Average Price Target
Wall Street Target
47.3 USD
-17.82%
VRNA Highest Price Target
Wall Street Target
74 USD
28.60%
REVENUE FORECAST
Revenue Forecast Chart VRNA
EBIT FORECAST
EBIT Forecast Chart VRNA
NET INCOME FORECAST
Net Income Chart VRNA